Importantly, the synthetic lethality of BRCA1/BARD1 with loss of H3K9me2 in Caenorhabditis elegans89, together with our findings, raises intriguing possibilities for therapeutic treatment of BRCA1-mutated cancer. This evidence concerns the gene BARD1 and cancer.